The ownership structure of Psyence Biomedical (PBM) stock is a mix of institutional, retail, and individual investors. Approximately 18.71% of the company’s stock is owned by Institutional Investors, and 81.59% is owned by Public Companies and Individual Investors.
The ownership structure of Psyence Biomedical (PBM) stock is a mix of institutional, retail, and individual investors. Approximately 18.41% of the company’s stock is owned by Institutional Investors, 0.31% is owned by Insiders, and 81.59% is owned by Public Companies and Individual Investors.
What percentage of Psyence Biomedical Ltd. (PBM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.57% of Psyence Biomedical Ltd. (PBM) stock is held by institutional investors.
What percentage of Psyence Biomedical Ltd. (PBM) stock is held by retail investors?
According to the latest TipRanks data, approximately 81.59% of Psyence Biomedical Ltd. (PBM) stock is held by retail investors.
Who owns the most shares of Psyence Biomedical Ltd. (PBM)?
AdvisorShares owns the most shares of Psyence Biomedical Ltd. (PBM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.